Our position on climate change

At Novo Nordisk we are committed to conducting our business in a financially, environmentally and socially responsible way. As climate change has global implications on all three dimensions, and poses a significant threat to human health and development, taking steps to reduce our impact is both an act of long-term risk mitigation and corporate responsibility.

Recognising that climate change and the diabetes pandemic are related to the consumption and lifestyle trends of high and middle income economies, taking actions to reduce carbon emissions are also an unprecedented opportunity to bring the world on a healthier, more sustainable course.

In the scientific debate, Novo Nordisk refers to the findings of the UN Intergovernmental Panel on Climate Change (IPCC).  We acknowledge the overwhelming scientific evidence of the IPCC experts and agree with the need to keep the temperature increase below 2 degrees Celsius as latest agreed by 195 countries at the COP 21 meeting in Paris in December 2015.

Novo Nordisk has signed up for the RE100 initiative[1] and pledged that all our electricity consumption for production will come from renewable sources by 2020. 

Novo Nordisk adheres to the principles of the Green House Gas Protocol (GHG protocol) when reporting and setting targets on carbon emissions. We aim to set targets consistent with the 2 degrees reduction pathway towards 2050 for Scope 1 and 2 and also to set ambitious targets for relevant Scope 3 activities.[2]

Novo Nordisk recognises the need to broaden the scope of climate action to the supply chain and will work with key suppliers to limit the carbon emission as the main priority under Scope 3. We will share experience and learnings and support the suppliers in finding the best carbon reducing measures, including energy efficiency and production or sourcing of renewable energy.

Novo Nordisk believes in reducing CO2 emissions by increasing the efficiency of our activities and implementing energy efficiency programmes. Secondly we base our consumption on renewable energy, where we cooperate with energy suppliers. When we source renewable energy we give priority to bringing additional renewable energy into the market.

Renewable energy can be based on wind, solar, hydro or biomass. When sourcing energy based on biomass, we ensure that the biomass comes from sustainable sources. Biomass, such as wood chips used for steam and heat production, must be based on sustainable sources certified by competent bodies. Biogas is based on our own yeast slurry and waste from farming and food industry.

Recognising the complexity and cross cutting nature of climate change, Novo Nordisk has taken a partnership approach to address this global challenge. We encourage partnerships and recognise that this approach often leads to better and more innovative solutions.

Novo Nordisk is a signatory to The UN Global Compact: Caring for Climate Leadership platform and has signed up for the RE 100 initiative.